OUTLOOK THERAPEUTICS, INC. Senior Notes, Noncurrent
OUTLOOK THERAPEUTICS, INC. (OTLK) had Senior Notes, Noncurrent of $13.23 million as of 2017-09-30, per its 10-K filed 2018-12-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent › Notes Payable, Noncurrent
us-gaap:SeniorLongTermNotes · last filed 2018-12-18
- 2017-09-30: Senior Notes, Noncurrent $13.23M.
| Period end | Senior Notes, Noncurrent |
|---|---|
| 2017-09-30 | $13.23M 10-K · filed 2018-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |